In vivo therapeutic effect of combination treatment with metformin and Scutellaria baicalensis on maintaining bile acid homeostasis
- PMID: 28877164
- PMCID: PMC5587228
- DOI: 10.1371/journal.pone.0182467
In vivo therapeutic effect of combination treatment with metformin and Scutellaria baicalensis on maintaining bile acid homeostasis
Abstract
The radix of Scutellaria baicalensis (SB) is a herb widely used in traditional Chinese medicine to treat metabolic diseases. Several main components, including baicalin and wogonoside, possess anti-dyslipidemia, anti-obesity and anti-diabetic effects. We hypothesized that co-administration of SB extract and metformin exerts a better effect on obesity-induced insulin resistance and lipid metabolism than treatment with metformin alone. We compared the effect of metformin (100 mg/10 mL/kg/day) alone with co-administration of metformin (100 mg/5 mL/kg/day) and SB extract (200 mg/5 mL/kg/day) on Otsuka Long Evans Tokushima Fatty rats, a useful model of type II diabetes with obesity, and used Long-Evans Tokushima Otsuka rats as a control. Weight, fasting glucose, oral glucose tolerance test, intraperitoneal insulin tolerance test, and serum total cholesterol were measured after 12 weeks of drug administration. We observed a synergetic effect of metformin and SB on lowering cholesterol level by excretion of bile acid through feces. We found that this accompanied activation of FXR, CYP7A1 and LDLR genes and repression of HMGCR in the liver. Although there were no significant changes in BSH-active gut microbiota due to high variability, functional prediction with 16S sequences showed increased primary and secondary bile acid biosynthesis in the combination treatment group. Further study is needed to find the specific strains of bacteria which contribute to FXR-related cholesterol and bile acid regulations.
Conflict of interest statement
Figures
Similar articles
-
The water extract of Radix scutellariae, its total flavonoids and baicalin inhibited CYP7A1 expression, improved bile acid, and glycolipid metabolism in T2DM mice.J Ethnopharmacol. 2022 Jul 15;293:115238. doi: 10.1016/j.jep.2022.115238. Epub 2022 Mar 26. J Ethnopharmacol. 2022. PMID: 35351576
-
Hypocholesterolemia of Rhizoma Coptidis alkaloids is related to the bile acid by up-regulated CYP7A1 in hyperlipidemic rats.Phytomedicine. 2012 Jun 15;19(8-9):686-92. doi: 10.1016/j.phymed.2012.03.011. Epub 2012 May 2. Phytomedicine. 2012. PMID: 22554715
-
Amelioration of hyperglycaemia and hyperlipidaemia by adjusting the interplay between gut microbiota and bile acid metabolism: Radix Scutellariae as a case.Phytomedicine. 2021 Mar;83:153477. doi: 10.1016/j.phymed.2021.153477. Epub 2021 Jan 21. Phytomedicine. 2021. PMID: 33545549
-
Bile acids as metabolic regulators.Curr Opin Gastroenterol. 2015 Mar;31(2):159-65. doi: 10.1097/MOG.0000000000000156. Curr Opin Gastroenterol. 2015. PMID: 25584736 Free PMC article. Review.
-
Interactions between gut bacteria and bile in health and disease.Mol Aspects Med. 2017 Aug;56:54-65. doi: 10.1016/j.mam.2017.06.002. Epub 2017 Jun 21. Mol Aspects Med. 2017. PMID: 28602676 Review.
Cited by
-
Exploring global research status and trends in anti-obesity effects of traditional Chinese medicine through intestinal microbiota: a bibliometric study.Front Cell Infect Microbiol. 2023 Nov 16;13:1271473. doi: 10.3389/fcimb.2023.1271473. eCollection 2023. Front Cell Infect Microbiol. 2023. PMID: 38045760 Free PMC article.
-
Multi-target regulation of intestinal microbiota by berberine to improve type 2 diabetes mellitus.Front Endocrinol (Lausanne). 2022 Nov 18;13:1074348. doi: 10.3389/fendo.2022.1074348. eCollection 2022. Front Endocrinol (Lausanne). 2022. PMID: 36465656 Free PMC article. Review.
-
The effect of Chinese herbal formulas combined with metformin on modulating the gut microbiota in the amelioration of type 2 diabetes mellitus: A systematic review and meta-analysis.Front Endocrinol (Lausanne). 2022 Sep 15;13:927959. doi: 10.3389/fendo.2022.927959. eCollection 2022. Front Endocrinol (Lausanne). 2022. PMID: 36187136 Free PMC article.
-
The interactions between traditional Chinese medicine and gut microbiota: Global research status and trends.Front Cell Infect Microbiol. 2022 Sep 12;12:1005730. doi: 10.3389/fcimb.2022.1005730. eCollection 2022. Front Cell Infect Microbiol. 2022. PMID: 36171760 Free PMC article.
-
The mechanism of berberine alleviating metabolic disorder based on gut microbiome.Front Cell Infect Microbiol. 2022 Aug 25;12:854885. doi: 10.3389/fcimb.2022.854885. eCollection 2022. Front Cell Infect Microbiol. 2022. PMID: 36093200 Free PMC article. Review.
References
-
- Wulffelé eM, Kooy A, Zeeuw Dd, Stehouwer C, Gansevoort R. The effect of metformin on blood pressure, plasma cholesterol and triglycerides in type 2 diabetes mellitus: a systematic review. J Intern Med. 2004;256(1):1–14. doi: 10.1111/j.1365-2796.2004.01328.x - DOI - PubMed
-
- Huang W-H, Lee A-R, Yang C-H. Antioxidative and anti-inflammatory activities of polyhydroxyflavonoids of Scutellaria baicalensis georgi. Biosci Biotech Bioch. 2006;70(10):2371–80. - PubMed
-
- Ye F, Xui L, Yi J, Zhang W, Zhang DY. Anticancer activity of Scutellaria baicalensis and its potential mechanism. J Altern Complem Med. 2002;8(5):567–72. - PubMed
-
- Kim EH, Shim B, Kang S, Jeong G, Lee J-s, Yu Y-B, et al. Anti-inflammatory effects of Scutellaria baicalensis extract via suppression of immune modulators and MAP kinase signaling molecules. J Ethnopharmacol. 2009;126(2):320–31. doi: 10.1016/j.jep.2009.08.027 - DOI - PubMed
-
- Jung H-S, Kim MH, Gwak N-G, Im Y-S, Lee K-Y, Sohn Y, et al. Antiallergic effects of Scutellaria baicalensis on inflammation in vivo and in vitro. J Ethnopharmacol. 2012;141(1):345–9. doi: 10.1016/j.jep.2012.02.044 - DOI - PubMed
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
